Legal Representation
Attorney
Laila S. Wolfgram
USPTO Deadlines
Next Deadline
1869 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-09-17)
Due Date
September 17, 2030
Grace Period Ends
March 17, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
30 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 17, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Sep 17, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Aug 10, 2024 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Aug 10, 2024 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| May 15, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| May 15, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Apr 19, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Apr 19, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Oct 24, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 29, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 29, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 9, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 27, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 27, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jul 27, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 27, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 27, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jul 17, 2023 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Jun 27, 2023 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
| Jun 14, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 13, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 12, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 12, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 26, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 26, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 26, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 25, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 30, 2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Aug 29, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 11, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Research and development of medications; Research and development of medications for preoperative use; Research and development of pharmaceutical compositions for administration prior to, during, or after a surgical procedure for conscious sedation
First Use Anywhere:
Aug 13, 2020
First Use in Commerce:
Aug 13, 2020
Additional Information
Design Mark
The mark consists of a stylized "M" formed by a plurality of green and blue dots arranged to form an irregular square, to the left of the term "MELT" in large blue lettering with the term "PHARMACEUTICALS" in smaller green lettering positioned below the center of the "M" of "MELT". The color white is not part of the mark and merely represent background or transparent areas of the mark.
Color Claim
The color(s) blue and green is/are claimed as a feature of the mark.
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS"